Abstract
Copyright © 2016, American Society for Microbiology. All Rights Reserved. Data on dolutegravir removal by hemodialysis are lacking. To study this, we measured dolutegravir plasma concentrations in samples of blood entering and leaving the dialyzer and of the resulting dialysate from 5 HIV-infected patients with end-stage renal disease. The median dolutegravir hemodialysis extraction ratio was 7%. The dolutegravir concentrations after the dialysis session remained far above the protein-binding-adjusted inhibitory concentration. Our results show minimal dolutegravir removal by hemodialysis, with no specific dolutegravir dosage adjustments required in this setting.
Original language | English |
---|---|
Pages (from-to) | 2564-2566 |
Journal | Antimicrobial Agents and Chemotherapy |
Volume | 60 |
Issue number | 4 |
DOIs | |
Publication status | Published - 1 Apr 2016 |